Display Settings:

Format

Send to:

Choose Destination
    Injury. 2009 Dec;40 Suppl 3:S8-11.

    Formulations and delivery vehicles for bone morphogenetic proteins: latest advances and future directions.

    Source

    Department of Surgery and Traumatology, University Medical Centre Utrecht, P.O. Box 85500, 3508 GA Utrecht, Netherlands. T.J.Blokhuis@umcutrecht.nl

    Abstract

    Growth factors are essential components of the diamond concept model. The bone morphogenetic proteins (BMPs) are the most potent and promising growth factors and their clinical efficacy is well demonstrated for specific indications. Application of BMPs involves a carrier material to enhance local residual time and pharmacokinetics. On the other hand carrier materials, collagen at this point, also limit the use of BMPs, for example in minimally invasive application methods. In this overview, the pharmacokinetics of BMPs, and various carrier materials (collagen, synthetic polymers, calcium phosphates, hyaluronic acid, CMC, and sodium acetate) are discussed. No other carrier material than collagen has been proven effective in clinical studies. Other formulations are needed to improve the residual time and handling.

    Copyright 2009 Elsevier Ltd. All rights reserved.

    PMID:
    20082796
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Elsevier Science

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk